Antipsychotic drugs; vendor drug program; Oklahoma Health Care Authority; prior authorized; disorders; prior authorization; effective date.
This bill requires Oklahoma's Medicaid program to approve prior authorization for atypical antipsychotic drugs not on the preferred drug list when treating mood disorders like schizophrenia, bipolar disorder, or related conditions. It mandates approval if a patient has failed a trial of a preferred drug in the past year or is stable on a non-preferred medication. The policy ensures these drugs are covered at parity with other branded medications in the same class, without additional restrictions beyond standard Medicaid criteria.
Bill status
passed
3 of 5 stages cleared
Introduction
Feb 2025
Committee Review
Mar 2025
House Passage
Mar 2025
Senate Passage
Governor
Introduced Feb 3, 2025
Last action Apr 1, 2025
Maddy AI version diff · 2 comparisons
What changed between versions
Engrossed
→
Floor (House)
·
3 edits
MINOR
The bill was reformatted from an 'Engrossed' version to a 'Floor Version' for the House of Representatives, with minor formatting adjustments to the header and page numbering. The substantive policy content regarding antipsychotic drug coverage, vendor drug programs, and prior authorization requirements remains unchanged.
TECHNICAL
Header text changed from 'ENGROSSED HOUSE' to 'HOUSE OF REPRESENTATIVES - FLOOR VERSION' to reflect the bill's current stage in the legislative process.
Page numbering and footer text were updated to reflect the House Floor version format, including adding a note that bold face denotes Committee Amendments.
Line breaks and spacing were adjusted throughout the document to conform to House Floor formatting standards.
Floor votes · House Mar 10, 2025
How they voted
88–0
Passed · 12 other
Total votes 100
Mar 10, 2025
D
Democratic19
73% Yea
R
Republican81
91% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
15
Key actions
5
Committee
4
Amendments
1
Mar 11, 2025
Introduced
First Reading
upper
Mar 11, 2025
Lower · Passed
Engrossed, signed, to Senate
lower
Mar 10, 2025
Committee
Referred for engrossment
lower
Mar 10, 2025
Lower · Passed
Third Reading, Measure passed: Ayes: 87 Nays: 0
lower
Mar 10, 2025
Lower · Passed
Amended
lower
Feb 26, 2025
Lower · Passed
CR; Do Pass Health and Human Services Oversight Committee
lower
Feb 24, 2025
Lower · Passed
Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public Health
lower
Feb 4, 2025
Committee
Referred to Public Health
lower
Feb 3, 2025
Introduced
First Reading
lower
2 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 2801
Scope: OK
Hi! I can help you understand HB 2801. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline